Pot stocks perk up premarket as BofA/ML turns bullish on Cronos
Cannabis producer Cronos Group (NASDAQ:CRON) is up 9% premarket on modest volume on the heels of an upgrade from Underperform to Buy with a $20 (from $13) price target at BofA/Merrill Lynch.
Breaking news on an upgrade of Cronos Group. I own the stock so this is welcome news, although I've been pretty aggressive selling the covered calls, might even sell more today. Long term I think the stock will do well, I'm just worried the overall market could be nasty in the near to mid term.....
Read the breaking news here....
https://seekingalpha.com/news/3469167-pot-stocks-perk-premarket-bofa-ml-turns-bullish-cronos?dr=1#email_link
Pre market Cronos is around $15.80.....
You got a 28.14% upvote from @spydo courtesy of @onthehook8! We offer 100% Payout and Curation to Delegator. Compare Return
Thanks
You got a 30.56% upvote from @brupvoter courtesy of @onthehook8!
Thanks
You got a 0.54% upvote from @minnowvotes courtesy of @onthehook8!
Thanks